Drug
Pyronaridine clinical trials
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2022 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 4
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (2) · Medicines for Malaria Venture (2) · London School of Hygiene and Tropical Medicine (1) · Armaceutica, Inc. (1) · Armed Forces Research Institute of Medical Sciences, Thailand (1)
Often tested with
Tested in the same studies.
Cabamiquine (2) · Atovaquone, proguanil drug combination (2) · Artesunate (2) · Piperaquine (1) · Primaquine (1) · Pyronaridine tetraphosphate, artesunate drug combination (1)
Studies
Open first, then newest update. How each study uses pyronaridine is read from its arms, and is right about nine times in ten.
Testing it · 7
- Pyronaridine in Acute Myeloid Leukemia (AML)SuspendedPhase 2Armaceutica, Inc.NCT05291390Written as Pyronaridine Tetraphosphate
- Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)CompletedPhase 2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05974267Written as Pyronaridine
- Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)CompletedPhase 2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05689047Written as Pyronaridine 360 mg
- Pyronaridine in Healthy Adult Participants Infected With Blood Stage MalariaCompletedPhase 1Medicines for Malaria VentureNCT05287893Written as Pyronaridine
- A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine TetraphosphateCompletedPhase 1Medicines for Malaria VentureNCT05160363Written as Pyronaridine Tetraphosphate
- Drug Combinations of Atovaquone-Proguanil (AP) With ACTStatus unknownPhase 4Armed Forces Research Institute of Medical Sciences, ThailandNCT03726593Written as Artesunate and Pyronaridine
- Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionCompletedPhase 2/3London School of Hygiene and Tropical MedicineNCT04049916Written as Pyronaridine Tetraphosphate/Artesunate
Codes
What other systems call pyronaridine · ClinicalTrials.gg INT002864
- MeSH (NLM) C027871pyronaridineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) TD3P7Q3SG6PYRONARIDINEConfirmed FDA, NLM, Wikidata
- Wikidata Q7263674pyronaridineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C90737PyronaridineOne source FDA
- DrugBank DB12975One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C027871 | pyronaridine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | TD3P7Q3SG6 | PYRONARIDINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7263674 | pyronaridine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C90737 | Pyronaridine | One source FDA |
| DrugBank | DB12975 | — | One source Wikidata |
Also registered as pyronaridine tetraphosphate (UNII 2T289F9ACO).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.